Podcasts about CSL

Applied to 50+ UX or Product jobs & still no interviews or offers? Get UX job search help.Welcome to the Career Strategy Podcast with Sarah Doody, a UX Designer & UX Researcher with 20 years of experience who founded the UX job search accelerator, Career Strategy Lab. She's been doing UX career coaching since 2017.Follow Sarah on: LinkedIn | YouTube | InstagramAfter 18 months of job searching with no results, Mariah was out of steam and questioning everything—until she joined Career Strategy Lab.In this Open House conversation, Sarah talks with Mariah, a UX researcher and experience strategist with a background in customer support and consulting. Mariah came to CSL after burning out from a year and a half of job searching while trying to relocate to Copenhagen. In this honest episode, she shares what finally helped her stop spinning, reconnect with herself, and gain the clarity, confidence, and support she'd been missing.Whether you're new to UX or deep in burnout, Mariah's story will remind you that it's not too late—and you don't have to figure it out alone.What You'll Learn in This Episode:✔️ What job searching for 18+ months taught Mariah about burnout and boundaries✔️ Why trying to “game the system” kept her stuck and exhausted✔️ How the Compass Sprint reconnected her to her voice, identity, and strengths✔️ Why the mindset calls inside CSL helped her finally feel like herself again✔️ How to balance personal and professional identity in your job search✔️ Her advice for perfectionists and overthinkers: take action, even when it's messyTimestamps:02:27 Mariah's Background and Career Journey04:21 Joining Career Strategy Lab: Initial Experiences08:09 Impact of Mindset Calls11:50 Tangible Actions and Career Roadmap18:43 Final Advice and Closing Remarks21:22 Podcast Outro and Additional Resources22:03 Special Message for Job Seekers⭐ Support the show! Leave a rating on Spotify or a review on Apple Podcasts to help more UX professionals find this podcast.

With Pfizer discontinuing Beqvez and BioMarin scaling back the commercial focus of Roctavian, the curative promise of hemophilia gene therapies is tempered by significant barriers that discourage widespread adoption. In this week’s episode of “The Top Line,” Fierce Pharma’s Zoey Becker speaks with Glenn Pierce, M.D., Ph.D., vice president of medical at the World Federation of Hemophilia, about the complexities behind these innovative therapies and the multifaceted reasons for their slow uptake. Pierce discusses the competitiveness of the current hemophilia gene therapy market, why Pfizer’s product couldn’t keep up, and the patient populations that risk being left behind. To learn more about the topics in this episode: As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay Pfizer discontinues hemophilia treatment Beqvez, emptying its gene therapy portfolio BioMarin downsizes Roctavian efforts but keeps hemophilia gene therapy for 3 markets See omnystudio.com/listener for privacy information.

The ASX 200 has finished the day down 22 points or 0.2%, trading in a narrow session as expected after not much of a US lead. Banks down, Resources slightly down. Technology stayed on top from midday. WTC, XRO gaining. 360, DDR and CAT best. Nasdaq futures slightly higher boosting sentiment. Health Care the only other sector to gain. CSL in the early stages of a V-shaped bounce. TLX staying in firm downtrend. The bottom not yet in sight. 4DX closing up 50%. Bringing the weekly move to 200% on more good news. REITs flat on the surface yet GDP and MGR managed modest gains. The sector as a whole not bouncing despite the 4.5bp drop in bond yields since Friday's close. Citi has said only to expect one more RBA rate cut this year.Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you.If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

CSL 裁员3000人，而公司利润明明在上涨。 这是否由AI 引发？普通人如何保住饭碗？Morgans 亚洲业务主管深度解析，点击收听，并欢迎您在SBS中文社交媒体平台留言，表达您的观点。

Ep. 328 You are Worthy…Simply Because - Rev. Dr. Mary Michell From the Sunday Service at the Center for Spiritual Living in Redding on 9-7-25

August reporting season closed with just 20–30% of companies beating expectations, as investors rewarded certainty in dividends, guidance, and cost control while punishing cautious outlooks. Standouts included Northern Star, Goodman Group, and JB Hi-Fi, while Woolworths, CSL, and James Hardie lagged on guidance misses. Looking to FY26, rate cuts, AI, gold, and resilient retailers are set to drive opportunity, but disciplined execution will be key.In this week's wrap, Grady covers:(0:16): a look back at reporting season as a whole(1:03): why investors are valuing clarity and strong guidance(2:03): a dive into some key sectors, including retail, gold and real estate(5:22): the themes shaping FY26's outlook(7:05): how the local market performed over the last trading week(7:32): the most traded stocks and ETFs this week(8:00): economic news items to look out for next week.

The ASX 200 has bounced back 88 points or 1% to 8827. Still down 72 points since the close on Tuesday. Financials stayed on top. ‘Big Three' plus MQG all up 2%. ANZ up 1.3%. ZIP up 3.6%. Gold the only sector in the red despite bullion maintaining its record high. Discretionary stocks no. 2. Most of the gain driven by WES up 2.5%. Has already recovered all its ex-dividend drop. DMP lost most of its morning gains. Tech no. 3. Not the huge bounce we were expecting following the Nasdaq's rise. XRO went from worst in the Top 50 to best. Up 4.8%. Good to see it, WES, CBA, MQG, NAB, WBC and PME along with HUB in the top gainers table. WTC lifeless and NXT finally gave it to a bout of profit taking.Defence stocks mixed as traders digest China's military show. EOS and ASB jumped while DRO and CDA only recorded small wins. Resources ended flat. Solid day from iron ore (back up to $105 in Singapore) and copper offset by gold. BHP only fell 31c vs its ~92c dividend. Lithium mixed. LTR, MIN and PLS all up over 1% while PMT and WC8 dropped. Excellent day for uranium. DYL up 6%, BOE up 5%, NXG up 4% and PDN up 2%. LOT closed at 18c (-20%) vs the 19c placement. Telecoms flat too. Health Care strong thanks to CSL and PME up 2.1% and 1.9%. 4DX the major mover. Up 13.4%. Backing up its huge 50% rise yesterday on US reimbursement certainty.Asian markets more converse since midday. Japan up 1%. China down 1.2%. No lead from US futures. Broadcom results early tomorrow morning.Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you. If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.  Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

What do seminary school, a dairy burn room, and running a global biotech powerhouse have in common? Paul Perreault. In this episode of The Authority Company Podcast, host Joe Pardavila sits down with Paul Perreault, former CEO of CSL and author of The Detour CEO, to explore how a non-linear path shaped his values-driven approach to leadership. Paul opens up about working 80-hour weeks in a restaurant, scrubbing burnt milk, and studying to become a priest—all before leading a multi-billion dollar company. He shares why being a generalist is underrated, how to separate identity from work, and what it really means to “add value” in life and business. Whether you're navigating your own professional pivot or leading a team, Paul's insights on humility, culture, and the myth of the corporate ladder are worth the listen.

Applied to 50+ UX or Product jobs & still no interviews or offers? Get UX job search help.Welcome to the Career Strategy Podcast with Sarah Doody, a UX Designer & UX Researcher with 20 years of experience who founded the UX job search accelerator, Career Strategy Lab. She's been doing UX career coaching since 2017.Follow Sarah on: LinkedIn | YouTube | InstagramWondering how to stand out in UX without burning out? Former technical recruiter Ellie shares her story of switching into product design—and how Career Strategy Lab helped her get her confidence back.In this episode, Sarah interviews Ellie, a former technical recruiter turned UX designer, who joined Career Strategy Lab while navigating new motherhood, burnout, and the unpredictable job market. Despite landing interviews, Ellie felt stuck—and knew she needed a structured, supportive way to rebuild confidence and stand out.You'll hear how she overcame perfectionism, reframed her job search, and built career habits that now extend beyond her portfolio and into her life.What You'll Learn in This Episode:✔️ Why Ellie left tech recruiting to pursue UX—and doesn't regret it✔️ What made her say “yes” to CSL (and why she wishes she joined sooner)✔️ How the Compass Statement gave her clarity and saved her time✔️ The unexpected life shifts that came from doing the work with intention✔️ Tips for breaking perfectionism and building habits that stick✔️ What it's like to join CSL while navigating new parenthood and burnoutTimestamps:00:00 Introduction to Career Strategy Lab00:38 Episode Overview and Open House Context02:23 Meet Ellie: From Technical Recruiter to Product Designer05:19 Ellie's Career Journey and CSL Experience09:16 The Impact of Career Strategy Lab18:47 Advice and Final Thoughts21:32 Conclusion and Next Steps⭐ Support the show! Leave a rating on Spotify or a review on Apple Podcasts to help more UX professionals find this podcast.

The guys destroy CSL and Reece’s WFH Excuse, Adir breaks down Site Minder’s huge surge, Qantas delivers a record result, Nvidia hits new highs but are grey skies looming, Blackbird’s Class of 2015, Sydney Outshines Dan Andrews’ Hellhole and KPop Rules. Thanks for listening! Join us on LinkedIn: https://www.linkedin.com/company/the-contrarians-with-adam-and-adir-podcast Subscribe on YouTube for all our video content: https://https://www.youtube.com/@ContrariansPodcast Follow us on Instagram: https://www.instagram.com/contrarianspod Follow us on TikTok: https://www.tiktok.com/@contrarianspodSee omnystudio.com/listener for privacy information.

Ep. 327 Love's Ascent - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 8-31-25

Two years ago Mark purchased CSL. The share has not done well in that period. Mark goes through his thoughts on CSL, whether it still meets his original thesis, and evaluates whether the share deserves a place in his portfolio.You can find the full article here. A message from Mark and ShaniFor the past five years, we've released a weekly podcast to arm you with the tools to invest successfully. We've always strived to provide independent, thoughtful analysis, backed by the work of hundreds of researchers and professionals at Morningstar.We've shared our journeys with you, and you've shared back. We've listened to what you're after and created a companion for your investing journey. Invest Your Way is a book that focuses on the investor, instead of the investments. It is a guide to successful investing, with actionable insights and practical applications.The book is currently in presale which is an important time to build momentum. If anyone would like to support this project you can buy the book now. Thanks in advance!Purchase from Amazon or Purchase from BooktopiaTo submit any questions or feedback, please email mark.lamonica1@morningstar.com or leave us a voicemail to feature on the podcast here.Audio Producer and mixer: William Ton. Hosted on Acast. See acast.com/privacy for more information.

While the aggregate numbers suggest this August reporting season hasn't been as volatile as previous ones—at least when looking at average share price moves on beats and misses—several big-name stocks have experienced outsized reactions. CSL, Woolworths and James Hardie were punished, while Coles, Brambles, and REA Group fared far better. Such sharp swings among large-cap “reliable” names have made the season feel more unpredictable than usual, particularly since these are the stocks investors typically buy for stability. They are also companies that dominate headlines and, understandably, get a lot of coverage. However, that also means that there are likely many companies beyond the headlines that delivered solid results, which the market might have overlooked. In this episode, Livewire's Anna Dadic is joined by Ben Rundle from Hayborough Investment Partners and Joe McCarthy from Elston Asset Management to run the ruler over three ASX names that quietly delivered strong results. For good measure, they each nominate another stock that may have flown under the radar —one they believe offers a compelling buying opportunity. Please note this episode was recorded on 27 August 2025.

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 22, 2025. In this episode: Madrigal regains MASH lead with EU Rezdiffra approval; Viking's obesity data scare investors; China assets lead GLP-1 deals; CSL and others restructure; and Indegene exec on DTP and MFN policies. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-T77LV22VANAL5GNPCC2YUVLZBE/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

The guys chat about CSL’s vaccine spin off and its share price disaster, just how good is Canva, Xero CEO’s lavish pay packet gets slammed by shareholders, Step One struggles to make a buck, RBA again fails basic understanding of how money works and Adam quizzes Adir on the world’s most valuable companies. Thanks for listening! Join us on LinkedIn: https://www.linkedin.com/company/the-contrarians-with-adam-and-adir-podcast Subscribe on YouTube for all our video content: https://https://www.youtube.com/@ContrariansPodcast Follow us on Instagram: https://www.instagram.com/contrarianspod Follow us on TikTok: https://www.tiktok.com/@contrarianspodSee omnystudio.com/listener for privacy information.

August 24, 2025 Talk Title: The Game of Life and How to Play It After a week of purposeful prayer and play at Seabeck camp, Kathianne and many others will fill the CSL sanctuary with the vibrations of positive possibility. Join in the Holy Fun.Speaker: Kathianne Lewis, DDwww.SpiritualLiving.orgTo donate to CSL Seattle: https://bit.ly/donate-cslseattleFor prayer support:PrayerRequest@spiritualliving.org206-524-7729 (PRAY)For a prerecorded Inspiration Line: 206-525-4438 (GIFT)#centersforspiritualliving #cslseattle #spiritualnotreligious

Ep. 326 The Turbulence of Love - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 8-24-25

– RBA’s $1.2b renovation – Economic roundtable disappointment – CSL, James Hardie and Audinate hit for six – Qantas’ $90m fine and NAB’s $130m make-good – CBA’s AI SNAFUSee omnystudio.com/listener for privacy information.

澳洲最大的製藥公司 CSL 周二宣布，將在全球裁員 3,000 人，公司認為最新業績未達投資者理想預期，需重組「簡化業務」。目前市場是否擔心，在疫情紅利冷卻後,醫藥股或難以東山再起？

The Aussie market eased on Friday, snapping its run of record highs as the ASX 200 slipped around half a percent to just under 9,000 points. Healthcare stocks weighed heavily, with CSL plunging after its restructure plans, while James Hardie also disappointed. On the flipside, Zip surged after strong US growth, while NRW and Helia posted gains. Ingham’s and Guzman y Gomez tumbled on results, and Regis Resources pulled back despite a strong year. Attention now shifts to Jerome Powell’s keynote at Jackson Hole and a busy week of earnings ahead, with results due from Coles, Woolworths, Qantas, Wesfarmers, and NVIDIA. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

The ASX 200 back below 9000 to 8967, down 52 points (0.6%) as results weighed after a long week. Banks remained firm with WBC up 0.7% and NAB slightly firmer, the Big Bank Basket drifting to $288.16 (-0.2%). Other financials also drifted lower, GQG fell 3.0% after early gains. Insurers firmed, ASX fell 2.1%, and ZIP soared 20.2% on better results. REITs were under pressure as GMG fell 4.8% on broker comments, SGP and CHC both better. Industrials slid, BXB saw some profit-taking, QAN dropped 2.1%, and ALL off 1.7%.Retail stocks also eased back, PMV down 4.0% and JBH falling 1.6%. GYG collapsed 18.2% after the results and a trading update. CTD in a trading halt awaiting some material news. Tech stocks eased back too, WTC down 1.8% and XRO continuing to fade. Down 0.6%. The All-Tech Index up 0.2%. WOW and COL under pressure. CSL resumed the downward momentum, off 4.2% as TLX trundled higher.In resources, BHP slightly lower, RIO fell 1.1%, and gold miners were mixed. WAF up 3.3% and VAU up again post results. Lithium stocks fell, PLS down 4.5% and MIN off 3.2%. Uranium stocks better, PDN up 4.3% and DYL rising 3.8%. Oil and gas firmed, coal stocks eased.In corporate news, ING dropped 20.3% as Woolies contract took its toll, HLS rallied 18.6% after results, AX1 dived 17.8% on disappointing sales growth, MVF fell 13.7% on disappointing profits and outlook.Nothing much on the economic front.Asian markets mixed again, Japan flat, China up 1.7% and HK up 0.5%European markets opening flat. US Dow futures down 18 Nasdaq down 32.Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you. If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.  Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

The ASX cracked the 9000 mark, up 101 points at 9019 (1.1%) as results buoyed sentiment. Some crackers today and, once again, plenty of volatility — even intraday.Banks provided the groundwork with CBA up 0.8% and ANZ again doing very well, up 1.5%, with the Big Bank Basket rising to $288.84 (1.0%). MQG had a good day, and financials generally did well. NWL was volatile post-results, down 0.6%, with GQG spurting 4.9% higher. ZIP also did well ahead of results tomorrow, up 2.6%.Insurers slipped a little, REITs firmed, SGP up 3.6% and SCG rising 1.3%. Industrials were firm too, TLS up 0.8% with WES running 2.5% higher. WOW and COL had good days as well, and BXB shot the lights out with results up 13.2%. CSL found bargain hunters up 2.4%. SHL smashed on results down 12.8%.Retailers continued to find favour, SUL hit record highs, up 12.3%. NCK gained 2.5%, and MYR rallied 4.0%. BRG also had a solid post-numbers bounce, up 4.9%.In resource land, BHP was again positive, up 0.7%, with RIO and FMG stronger too. Gold miners enjoyed a bullion rise, and results from NST, VAU, and GMD were somewhat mixed. Lithium stocks were back in favour, PLS up 5.2% with MIN higher 4.5%, and LYC also doing well, up 4.5%. JHX continued to be walloped, down 9.4%.Oil and gas names were stronger on crude rises, WDS up 1.3% with BPT up 1.2%. Coal stocks improved, and uranium was generally firm.In corporate news, some cracking results today: SUL, BGA, with IPH falling 19.5% as it warned on US patent impacts. GMG eased 1.4%, with results in line, while QUB fell 0.4% on a large write-down. MP1 fought back from an early drop to close only modestly lower. TLX jumped 7.0% after a wobbly start. Nothing much on the economic front.Asian markets mixed again, Japan down 0.6%, China up 0.5% and HK down 0.3%European markets opening flat. US Dow futures down 44 Nasdaq unchanged.Want to invest with Marcus Today? The Managed Strategy Portfolio is designed for investors seeking exposure to our strategy while we do the hard work for you. If you're looking for personal financial advice, our friends at Clime Investment Management can help. Their team of licensed advisers operates across most states, offering tailored financial planning services.  Why not sign up for a free trial? Gain access to expert insights, research, and analysis to become a better investor.

The ASX 200 ended modestly higher after a choppy session, with investors digesting profit results and awaiting a key speech from US Fed Chair Jerome Powell. Heavy losses in miners and healthcare, including further weakness in CSL, were offset by strong gains in the big banks. James Hardie slumped on weak US demand, while Breville and Iluka also disappointed. On the upside, Magellan, Stockland, Lottery Corp and Transurban all posted strong results and lifted sharply. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Applied to 50+ UX or Product jobs & still no interviews or offers? Get UX job search help.Welcome to the Career Strategy Podcast with Sarah Doody, a UX Designer & UX Researcher with 20 years of experience who founded the UX job search accelerator, Career Strategy Lab. She's been doing UX career coaching since 2017.Follow Sarah on: LinkedIn | YouTube | InstagramLaid off and wondering if you've “missed your shot”? This story will change how you think about career momentum.In this Open House conversation, Sarah sits down with Manny, a senior UX designer who transitioned into UX after a decade in graphic design and just landed a role at Fidelity. After getting laid off and spending weeks spinning his wheels, Manny joined Career Strategy Lab to bring clarity, structure, and confidence back to his job search.In this honest and insightful conversation, Manny shares what helped him rebuild momentum, how the Compass Sprint shaped everything from his resume to interviews, and why he wishes he'd joined sooner.What You'll Learn in This Episode:✔️ How Manny landed a UX role at Fidelity after being laid off✔️ The single most valuable CSL exercise (that he didn't expect)✔️ Why clarity leads to faster progress across your materials✔️ How the Compass Statement helped him shape his story and stand out✔️ Why applying early in your job search saves you time, money, and confidence✔️ How to make the most of CSL—whether you're employed or notTimestamps:02:28 Meet Manny: A UX Designer's Journey03:51 Navigating Job Search Challenges06:16 The Impact of Career Strategy Lab12:27 Advice for UX Job Seekers14:54 Conclusion and Final Thoughts15:07 Podcast Outro and Additional Resources15:47 Special Message for Job Seekers⭐ Support the show! Leave a rating on Spotify or a review on Apple Podcasts to help more UX professionals find this podcast.

Qantas has copped a record $90 million fine for its illegal sackings of staff…and more than half of the money is going straight to the union. CSL, the Aussie biotech, is cutting almost 3000 staff globally, as part of the biggest shake-up of the last decade. Soho House, the members club, is going private again after battling in the public markets for the past 4 years. _ Learn more about iShares by BlackRock here Download the free app (App Store): http://bit.ly/FluxAppStore Download the free app (Google Play): http://bit.ly/FluxappGooglePlay Daily newsletter: https://bit.ly/fluxnewsletter Flux on Instagram: http://bit.ly/fluxinsta Flux on TikTok: https://www.tiktok.com/@flux.finance —- The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.__ Issued by BlackRock Investment Management (Australia) Limited ABN 13 006 165 975, AFSL 230 523. Refer to FSG available on our website. Before making any investment decisions, you should assess whether the product or service is appropriate for you and read the PDS and TMD available at blackrock.com.au.See omnystudio.com/listener for privacy information.

SBS Finance Editor Ricardo Gonçalves speaks with Woodside Energy CEO Meg O'Neill and BHP CFO Vandita Pant following their profit results, while FTSE Russell Julia Lee goes through the day's market action including why investors slammed CSL.

One stock accounted for almost of the declines across the ASX today. Steve joins the podcast to reflect on the end to the recent winning streak bringing the first decline in a while. He discusses the imminent US rate cut decision, the Aussie sectors with healthcare seeing substantial declines amid CSL shares dropping more than 16%. Seek was one of the winners today following their latest results, and Steve looks to the day ahead with CBA set to go ex-dividend, and major US retail stocks expected to release their earnings data as the week continues. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

CSL has suffered its biggest single day fall on the market, dropping 17% and wiping $20 billion from the company’s value MARKET WRAP: ASX200: down 0.7% to 8,896 GOLD: $3,337/oz BITCOIN: $178,089 CURRENCY UPDATE: AUD/USD: 64.9 US cents AUD/GBP: 48.0 British pence AUD/EUR: 55 Euro cents AUD/JPY: 96 Yen AUD/NZD: 1.09 NZ dollars See omnystudio.com/listener for privacy information.

The market's run towards 9000 points was halted by a bad day for CSL, which lost 17% after announcing it would cut 3000 jobs.See omnystudio.com/listener for privacy information.

CSL to slash 3,000 jobs in major restructure, the government’s economic roundtable kicks off in Canberra. Plus, Challenger posts a nine per cent profit jump to $456 million.See omnystudio.com/listener for privacy information.

Wall Street held steady as investors brace for the Jackson Hole Symposium, while the US dollar climbed as Donald Trump hosted talks on Ukraine. Elsewhere, Private equity giant Thoma Bravo was reported to be in discussions to acquire software firm Dayforce, and the Trump administration is weighing a potential 10% stake in Intel. Solar stocks gained on the back of a favorable tax credit ruling, while US bonds rose as bets on a September rate cut remained intact. Back home, Aussie shares are set to retreat from record highs, with investors eyeing earnings results from Woodside Energy, BHP, and CSL. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Ep. 325 Soaring in Love - Lewanna Godinez From the Sunday Service at the Center for Spiritual Living in Redding on 8-17-25

Ep. 323 The Launch of Love - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 8-3-25

Ep. 324 Love's Ascent - Rev. Lynn E. Fritz From the Sunday Service at the Center for Spiritual Living in Redding on 8-10-25

As the world's largest biotech partnering event took place in Boston in June, MTPConnect was there introducing an Australian delegation to the Boston ecosystem, hosting business events to drive international collaborations and leading the Australian Pavilion to highlight Australia's fast-growing life sciences sector to the international biotech industry.Our CEO Stuart Dignam was on the ground to find out why people are making the trip to BIO and what the buzz is all about. In this episode, Stuart speaks to Brent Owens, co-founder of Ballarat-based Vitrafy Life Sciences – a company pioneering cryopreservation technology and Brent Barnes, CEO and Manager Director of Adelaide-based Clever Culture Systems - inventor of APAS Independence, an intelligent microbiology culture plate reading technology that is revolutionising pharmaceutical lab work. These Australian start-ups have established a foothold in the US and are looking to expand and navigate the new tariff regime. Stuart also catches up with Professor Chris Molloy from the UK's Medicines Discovery Catapult to get his take on BIO and find out more about the BIOBridge initiative and why collaboration is key to solving the world's health challenges. For the support and partnership, MTPConnect would like to thank the state governments of NSW, Victoria, Queensland, Western Australia and South Australia, and the Department of Industry, Science and Resources, Austrade, CSIRO and AusBiotech.And thanks for the industry support from Moderna, Novartis, Australia & New Zealand, Cytiva, Sanofi, Arrotex Pharmaceuticals and Nutromics, and support for MTPConnect's Australian delegation site visit program from CSL and Global Pharma Solutions. 

This episode originally aired on June 7, 2021: This week we're bringing you a documentary where CSL students Brook Kelela and Ashley Krehut explore the significance of outdoor gardens in our communities. Listen in for discussions of food security, food sovereignty, and more!Original broadcast: 5 May 2021Prairie Urban Farm: http://www.prairieurbanfarm.ca/ Veg in YEG: https://veginyeg.ca/ Further listening: Seeds! https://terrainforma.ca/220Urban Beekeeping https://terrainforma.ca/209Indigenous Food Sovereignty: Wild Meat, Wild Stories https://terrainforma.ca/102Program Log ★ Support this podcast ★

Ron Pevny, founder and director of the Center for Conscious Eldering, shares wisdom on living a fulfilling, purpose-driven second half of life.As today's seniors redefine what it means to age, Conscious Living, Conscious Aging offers wisdom and practical tools for navigating this new chapter with vitality, engagement, and spiritual depth. Pevny introduces Conscious Eldering as a pathway to personal growth, service, and lifelong exploration, helping readers cultivate meaning, navigate life transitions, and embrace their elder years with intention. This conversation will explore how aging can be a time of transformation, contribution, and deep fulfillment.Ron Pevny, M.A., CSL has for forty years been dedicated to assisting people in negotiating life transitions as they create lives of purpose and passion. He is Founding Director of the Center for Conscious Eldering, based in Colorado, which for 20 years has presented workshops and retreats across North America to support people in bringing purpose, growth and commitment to service to their elder years. He is author of Conscious Living, Conscious Aging: Claiming the Gifts of Elderhood, published by Beyond Words/Atria Books in 2014, with a new, 10th Anniversary expanded and updated edition published this past July. Ron is also a Certified Sage-ing® Leader, and has served as the host/interviewer for three Transforming Aging Summits presented by The Shift Network and co-host for the Turning Points interview series presented by Sage-ing International.

Ep. 322 Going Deeper - Gary Lynn Floyd From the Sunday Service at the Center for Spiritual Living in Redding on 7-27-25

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has dropped an early-stage obesity asset, CT-173, citing lack of competitiveness. Novartis has entered into a drug discovery deal with Matchpoint Therapeutics, acquiring global rights on all molecules for several inflammatory diseases. AstraZeneca claims a Phase III win with its nanobody treatment for myasthenia gravis. Second-quarter earnings season is approaching, and biotechs to watch include Sarepta and others facing challenges in the biopharma industry. Genentech downsizes as priorities shift, and GSK's comeback for Blenrep is on pause as the FDA delays its decision. The FDA's lack of transparency has tarnished Sarepta's reputation after patient deaths triggered an FDA battle. Opportunities in the industry include roles like Quality Specialist at CSL and Clinical Research Physician at Eli Lilly and Company.

The Aussie market slipped on Friday as miners gave back gains and financials dragged, capping a choppy week that saw markets flirt with record highs. Energy outperformed thanks to rising oil prices, while Newmont hit a fresh high and CSL lifted healthcare back into positive territory for the year. AMP pulled back despite strong earlier gains. With inflation data, retail trade, central bank decisions and earnings from Microsoft, Meta and Amazon all ahead, next week is set to be one of the biggest of the year. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

The Aussie market snapped its winning streak despite a strong US lead, with the ASX200 turning lower after RBA Governor Michele Bullock warned inflation may not fall as quickly as hoped. That cast doubt over an August rate cut, even as markets still expect it. Fortescue jumped on record iron ore shipments, while Bapcor plunged 29% on a profit warning. CSL helped lift healthcare, the only sector in the green, and Macquarie fell on leadership changes. We also cover moves from PEXA, Boss Energy, and Lynas Rare Earths, plus results from Alphabet and Tesla. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

MARKET WRAP: ASX200: down 0.3% to 8,709 GOLD: $3,363 USD/oz BITCOIN: $179,152 CSL advancing 1.5%, to $269.56 Sonic Healthcare and Resmed were also higher. Clarity pharmaceuticals jumped 10% to $4.31 Fortescue's shares rose by 4.3% to $19 after it announced a record volume of iron ore shipments and projected stronger growth. Lynas Rare Earths gained more than 5% to $10.65 Bapcor saw its shares plummet by 28% to $3.66 after it saw weaker sales over the last couple of months. Northern Star Resources dipped by 2.4% Also falling backwards was BHP, Wesfarmers and Macquarie Group AUD/USD: 66.2 US Cents AUD/GBP: 48.9 British Pence AUD/EUR: 56 Euro Cents AUD/JPY: 97 Yen AUD/NZD: $1.09 NZSee omnystudio.com/listener for privacy information.

Applied to 50+ UX or Product jobs & still no interviews or offers? Get UX job search help.Welcome to the Career Strategy Podcast with Sarah Doody, a UX Designer & UX Researcher with 20 years of experience who founded the UX job search accelerator, Career Strategy Lab. She's been doing UX career coaching since 2017.Follow Sarah on: LinkedIn | YouTube | InstagramTired of vague AI tools that spit out generic resume rewrites and surface-level portfolio tips? Meet the smarter alternative.In this episode, Sarah shares the behind-the-scenes strategy behind Sage—the AI agent exclusively available inside Career Strategy Lab—and why it's already helping job seekers finish their resumes, portfolios, and LinkedIn profiles faster without sacrificing clarity or confidence.You'll learn why this tool is more than just a shortcut—it's a UX-informed, coach-trained experience designed to get you unstuck and back into momentum, 24/7.What You'll Learn in This Episode:✔️ The two problems most UX job seekers face: info overload + execution overwhelm✔️ Why most AI job search tools fail (and how Sage is different)✔️ How Sage is trained on CSL's proven curriculum and thousands of real conversations✔️ Why context-specific feedback beats ChatGPT every time✔️ How CSL members are using Sage to move faster and stop second-guessing✔️ The one mindset shift that will help you use AI effectively in your careerTimestamps:00:00 Introduction and Common Job Search Struggles00:46 Introducing Career Strategy Lab's AI Tools02:01 Why UX Professionals Struggle in Job Searches02:39 The Problems Our AI Tools Aim to Solve06:53 How Our AI Tools Work13:58 Demo of Sage, Our AI Agent27:51 Benefits of Using Sage29:36 Conclusion and Call to Action

Ep. 321 Honoring - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 7-20-25

The Aussie sharemarket surged today, coming within just seven points of a record high. All sectors except mining finished in positive territory, with tech stocks and CSL helping lead the gains. Laura and Stevie unpack a raft of Chinese economic data, including GDP figures that slightly beat expectations, and preview a busy 24 hours ahead with key US inflation data and major bank earnings due. Plus, we look at a few notable movers from today's session - Lifestyle Communities, Paladin, Tyro, HUB24, and oOh!media. The content in this podcast is prepared, approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399 AFSL 238814. The information does not take into account your objectives, financial situation or needs. Consider the appropriateness of the information before acting and if necessary, seek appropriate professional advice.See omnystudio.com/listener for privacy information.

Applied to 50+ UX or Product jobs & still no interviews or offers? Get UX job search help.Welcome to the Career Strategy Podcast with Sarah Doody, a UX Designer & UX Researcher with 20 years of experience who founded the UX job search accelerator, Career Strategy Lab. She's been doing UX career coaching since 2017.Follow Sarah on: LinkedIn | YouTube | InstagramFeel like you're doing everything “right” and still not getting anywhere? You might be saying yes to too much—and it's slowing you down.In this episode, Sarah shares how one of Steve Jobs' greatest strengths—his ability to say no—has shaped the design of Career Strategy Lab and her own career choices. You'll hear how saying no to shiny objects, distractions, and opportunities that seem exciting on the surface actually leads to deeper results, more momentum, and a better UX for job seekers inside CSL.Whether you're applying to every job that pops up, overcommitting to upskilling, or trying to be everything to everyone, this episode is a reminder that focus is a strategy—and saying no is a skill.What You'll Learn in This Episode:✔️ What Steve Jobs' product philosophy can teach you about your UX career✔️ How Sarah decides what to say no to in her business—and why it matters✔️ Why not doing “all the things” actually creates better outcomes for clients✔️ The trade-offs you're making every time you say yes✔️ How saying no led to CSL's newest AI tool + all-in-one experience✔️ 3 reflection questions to help you narrow your focus and move forwardTimestamps:01:50 Steve Jobs' Focus Strategy03:55 Applying Focus in My Career08:01 The Importance of Specialization11:47 Real-Life Examples of Saying No13:28 The Ripple Effect of Focus17:50 Final Thoughts and Career Advice20:07 Conclusion and How to Connect⭐ Support the show! Leave a rating on Spotify or a review on Apple Podcasts to help more UX professionals find this podcast.

Ep. 320 Breathe - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 7-13-25

SBS Finance Editor Ricardo Gonçalves speaks with Darren Thompson from Equity Trustees about the day's sharemarket action including Nvidia's record run and CSL's response to Trump's proposed tariffs; plus Stephanie Youssef finds out why rental price growth is stalling with Nicola Powell from Domain.

¡Como me gusta este podcast! ¡Como me gustan estos coches! Excesivos, brutales… sencillamente son, para mí, los coches de competición en circuito más espectaculares de la historia. Fruto de un reglamento poco restrictivo… no como los de ahora… Si conoces los “Silueta” te va a interesar mucho este video, pero si nos los conoces… ¡te va a interesar más! Te lo prometo. Lo primero que hay que hacer, porque quizás alguno no lo sepa, es responder a esta pregunta: ¿Qué es un coche “silueta”? Lo primero que hay que decir es que los “silueta” son coches del entonces llamado Grupo 5, pero no todos los grupo 5 son coches de la categoría “silueta”. Los Grupo 5 nacieron en 1966 e inicialmente eran coches nacidos para la competición. Te pongo algunos ejemplos: Alfa Romeo TT33TT/12, Alpine Renault A442, Ford GT40, Ferrari 512 M/S, Matra Simca MS670 o Porsche 917 por citar unos ejemplos… coches preciosos y que, seguro, merecen otro video para ellos. Pero en 1976 y hasta 1982, época de mi adolescencia y juventud, nace la cuarta y última generación del Grupo 5 y estos son los “silueta”. La FIA creó esta categoría para coches derivados de la calle, pero ampliamente, yo diría que muy ampliamente, modificados. La federación exigía que el capó, parabrisas, puertas completas y techo fueran los mismos que en el coche original. Pero lo demás, incluidos los pasos de rueda y la parte posterior era libre. El motor debía contar con el bloque motor original y en la posición original. Es decir, no podías hacer un 911 con motor delantero, pero sí ponerlo más bajo o más adelantado y prepararlo a fondo, incluso aumentando la cilindrada o añadiendo “turbos” a placer siempre que el bloque fuese original. Lo mismo sucedía con la suspensión, debía ser de igual sistema, pero de diseño y componentes libres. Había exigencias en cuanto a normas de seguridad, pesos mínimos y dimensiones, pero en general las normas eran muy “laxas” y ello dio lugar a verdaderos monstruos de la competición… ¿Qué no te lo crees? Vamos a ver unos cuantos… 1. BMW 3.0 CSL (1972). Uno de los primeros trabajos del departamento M fue la fabricación de un coupé de la serie E9 para ser preparado para competición. 2. Lancia Stratos Turbo (1976). Terminada su etapa en los Rallyes el Stratos tuvo una segunda oportunidad en los circuitos de la mano del reglamento de los silueta… pero no tan exitosa. 3. Chevrolet Corvette Greenwood (1976). He elegido de este modelo la versión denominada “Spirit of Le Mans 1976”. Este coche, como un Ferrari que veremos más adelante, participaba dentro de una categoría de la norteamericana IMSA. 4. Porsche 911-935 (1976). Uno de los “silueta” por excelencia. Y en el caso concreto del 911-935 de nominado “Moby Dick” probablemente el más brutal de todos y al que dedicamos un video completo titulado “Moby Dick: el Porsche Turbo más brutal” que te animo a que lo veas. 5. BMW 320i Turbo (1977). El CSL era demasiado grande y demasiado antiguo así que BMW pensó en un más manejable serie 3, pero eso sí, con turbo y una potencia que según algunas fuentes llegaron a los 900 CV… 6. Ferrari 512 BB LM (1977). Este coche corrió Le Mans encuadrado en la categoría norteamericana IMSA… que fue prohibida en esta prueba en 1983. 7. Toyota Celica LB Turbo (1977). El apoyo de Toyota Alemania al preparador, muy prestigioso, Schnitzer, hizo posible que naciese este modelo que declaraba 560 CV para un peso claramente por debajo de los 900 kg. 8. Ford Capri Turbo Zakspeed (1978). Ford quiso competir en la categoría “hasta 2 litros” del Grupo 5 “siluetas” y para ello encargó al prestigiosos preparados Zakspeed un motor de 1.4 litros para montar en un espectacular y aerodinámico Ford Capri. 9. Lancia Beta Montecarlo Turbo (1979). Lancia tenía una base excelente, como era el coupé Montecarlo con dos plazas y motor central, para crear un silueta destinada al Grupo 5 de la FIA. 10. Mazda RX-7 252i (1979). El grupo 5 “Silueta” tuvo continuidad en Japón una vez acabada su vida en Europa, en el Campeonado del Mundo FIA. Y hubo muchos coches japoneses preparados bajo este reglamento. Conclusión. Siempre digo lo mismo: Los reglamentos actuales son tan estrictos y tan detallados que dejan poco a la imaginación… antes no era así y eso producía coches como estos, como los Grupo B, como los prototipos y Formula 1 de los años 70 y 80.

Ep. 319 Remembering - Rev. Sue MillerBorn From the Sunday Service at the Center for Spiritual Living in Redding on 7-6-25